Patent Baristas

Maybe we’re on to something with coffee and legal work. The Editor of the Blawg Review suggested we trademark Patent Baristas and set up a new shop after seeing this posting on George Lenard’s Employment Blawg (photo by Fifi LePew/Marcia Cirillo via flickr) We won’t ask why he was looking for “law & coffee” but […]

The U.S. Court of Appeals for the District of Columbia Circuit ruled that Pfizer and other drug companies have the right to sell unbranded versions of their own drugs even if they undercut sales of generic competitors in a suit by Teva Pharmaceutical, which sought to stop Pfizer from selling its own generic version of […]

It appears that the Commonwealth of Kentucky has it out for blogs. As detailed by Ben Cowgill on his Legal Ethics Blog, the Kentucky Attorney’s Advertising Commission has taken the position that a weblog is an advertisement. This is the result of Rule 7.02 of the Kentucky Code, which states: 7.02 “advertise or “advertisement” means […]

Bill Heinze of I/P Updates recently posted a note about “A Step-By-Step Guide To Getting a Patent,” which ran in the Wall Street Journal’s Startup Journal. The article quotes a U.S. Patent Office spokeswoman as saying that 63% to 65% of applications are eventually allowed as patents, but then displays the following “reality check:” I […]

We’ve gotten behind in some (OK, a lot) of to-do items on the site so we’ll try to get caught up on some housecleaning. One item of note is that the Patent Baristas received a nice mention by Monica Bay in the Common Scold. Besides being editor-in-chief of Law Technology News, editorial director of Law […]

There has been a flurry of news reports this year showing the heightened awareness of the biotech industry and the concomitant growth. Business Week recently published an article touting that Biotechnology has finally come of age after 30 years of biological research. Now, recent developments in gene and exotic chemical manipulation have brought a wave […]

Food and Drug Administration regulators turned down a request from Johnson & Johnson to expand the approved uses for Risperdal, a treatment for bipolar disorder. J&J received a not approvable letter from the FDA to use Risperdal in Alzheimer’s-related psychoses. This is after last weeks announcement that the FDA rejected J&J’s application to market Risperdal […]

The TechnoLawyer Blog, an amalgam of pithy commentary, industry news, and other helpful information compiled by Neil Squillante and Sara Skiff, is sponsoring the Eighth Annual TechnoLawyer @ Awards where TechnoLawyer members vote for their favorite products, services, and Web sites in a variety of categories. Yes, the Patent Baristas are simply far too modest […]